M. Maynard-Muet

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Vlad Ratziu, Stephen A. Harrison, Sven Francque et al. · Gastroenterology · 2016 · 1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

A Poxvirus Vaccine Is Safe, Induces T-Cell Responses, and Decreases Viral Load in Patients With Chronic Hepatitis C

François Habersetzer, Géraldine Honnet, Christine Bain et al. · Gastroenterology · 2011 · 86 citations

Life Sciences, Immunology, Infectious Diseases +17

Prevalence and significance of anticardiolipin, anti‐β₂ glycoprotein I and anti‐prothrombin antibodies in chronic hepatitis C

Vincent Leroy, J Arvieux, Marie‐Christine Jacob et al. · British Journal of Haematology · 1998 · 83 citations

Medicine, Immunology, Internal Medicine +15

Longitudinal Liver Stiffness Assessment in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy

Stella Maris Martínez, Juliette Foucher, Jean-Marc Combis et al. · PLoS ONE · 2012 · 69 citations · Full text

Medicine, Internal Medicine, Diagnostic Imaging +15

Role of anti-interferon antibodies in breakthrough occurrence during alpha 2a and 2b therapy in patients with chronic hepatitis C

Vincent Leroy, M Baud, Caroline de Traversay et al. · Journal of Hepatology · 1998 · 48 citations

Life Sciences, Immunology, Pharmacotherapy +15